Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV

Published:2023-07-01 Issue:8 Volume:37 Page:1341-1342
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Jiang Rui,Sun Jianjun,Zhao Bihe,Zhang Renfang,Liu Li,Chen Jun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference10 articles.

1. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients;Zhang;Signal Transduct Target Ther,2021

2. Small molecules in the treatment of COVID-19;Lei;Signal Transduct Target Ther,2022

3. Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance;Ross;AIDS,2004

4. Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro;Wang;PLoS One,2014

5. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China;Wang;BMC Infect Dis,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azvudine;Reactions Weekly;2023-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP